Search Results - "Cruceta, A"

Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxis by Inciarte, A, Leal, L, González, E, León, A, Lucero, C, Mallolas, J, Torres, B, Laguno, M, Rojas, J, Martínez-Rebollar, M, González-Cordón, A, Cruceta, A, Arnaiz, J A, Gatell, J M, García, F

“…To assess HIV-1 post-exposure prophylaxis (PEP) non-completion at day 28, comparing ritonavir-boosted lopinavir versus cobicistat-boosted elvitegravir as a…”
Get full text

Network meta‐analysis of post‐exposure prophylaxis randomized clinical trials by Fernández, I, Lazzari, E., Inciarte, A., Diaz‐Brito, V., Milinkovic, A., Arenas‐Pinto, A., Etcheverrry, F., García, F., Leal, L, Fernandez, E, Gonzalez, E, Lucero, C, Leon, A, Garcıa, F, Manzardo, C, Nicolas, D, Bodro, M, del Rıo, A, Cardozo, C, Cervera, C, Pericas, JM, Sanclemente, G, de la Calle, C, Morata, L, Soriano, A, Espinosa, G, Blanco, J ́L, Martınez, E, Mallolas, J, Miró, J, Laguno, M, Rojas, J, Martınez‐Rebollar, M, Gonzalez‐Cordon, A, Cervera, C, Knobel, H, Peraire, J, Domingo, P, Clotet, B, Dalmau, D, Cruceta, A, Arnaiz, JA, Gatell, JM

“…Objectives We performed a network meta‐analysis of PEP randomized clinical trials to evaluate the best regimen. Methods After MEDLINE/Pubmed search, studies…”
Get full text

Increasing needs of support on clinical trials in advanced Therapies by Varea, S, Pich, J, Cruceta, A, Encinas, C, Arnaiz, J.A

“…Discussion The first administration in humans of an investigational medicinal product, whether conventional (chemical, biological) or advanced (cellular,…”
Get full text

Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy by MARTINEZ, Esteban, BLANCO, José L, CARNE, Xavier, PHILLIPS, Andrew, GATELL, José M, ARNAIZ, Juan A, PEREZ-CUEVAS, José B, MOCROFT, Amanda, CRUCETA, Anna, MARCOS, Maria A, MILINKOVIC, Ana, GARCIA-VIEJO, Miguel A, MALLOLAS, Josep

“…To assess the incidence and risk factors for hepatotoxicity associated with nevirapine. A prospective cohort study in a teaching and referral hospital…”
Get full text

Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV–HCV co-infected patients: final results of the Spanish BOC HIV–HCV Study by Laguno, M., Von Wichmann, M.A., Van den Eynde, E., Navarro, J., Cifuentes, C., Murillas, J., Veloso, S., Martínez-Rebollar, M., Guardiola, J.M., Jou, A., Gómez-Sirvent, J.L., Cervantes, M., Pineda, J.A., López-Calvo, S., Carrero, A., Montes, M.L., Deig, E., Tapiz, A., Ruiz-Mesa, J.D., Cruceta, A., de Lazzari, E., Mallolas, J.

“…Boceprevir (BOC) was one of the first oral inhibitors of hepatitis C virus (HCV) NS3 protease to be developed. This study assessed the safety and efficacy of…”
Get full text

Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir by Rojas, J, Lonca, M, Imaz, A, Estrada, V, Asensi, V, Miralles, C, Domingo, P, Montero, M, Rio, L, Fontdevila, J, Perez, I, Cruceta, A, Gatell, JM, Arnedo, M, Martínez, E

“…Objective To assess whether changes in antiretroviral drugs other than thymidine nucleoside reverse transcriptase inhibitors (NRTI) may have a body fat impact…”
Get full text

Transmission of Hepatitis C Virus by Discarded-Needle Injury by Libois, Agnès, Fumero, Emilio, Castro, Pedro, Nomdedeu, Meritxell, Cruceta, Anna, Gatell, José Maria, Garcia, Felipe

Get full text

Long-term Clinical Follow-up, without Antiretroviral Therapy, of Patients with Chronic HIV-1 Infection with Good Virological Response to Structured Treatment Interruption by Florence, Eric, García, Felipe, Plana, Montserrat, Fumero, Emilio, Castro, Pedro, Lopez, Anna, Cruceta, Anna, Gil, Cristina, Arnedo, Mireia, Miró, José M., Pumarola, Tomás, Gallart, Teresa, Gatell, José M.

“…The present study assessed the long-term clinical follow-up of 26 of 60 human immunodeficiency virus (HIV)—positive patients who followed structured treatment…”
Get full text

A randomized trial comparing the efficacy and tolerability of two HAART strategies at two years in antiretroviral naive patients by Mallolas, J, Blanco, J L, Pich, J, Arnaiz, J A, Peña, J M, Dalmau, D, de Lazzari, E, Ochoa, A, Vidal, F, Ribas, M A, Segura, F, Pedrol, E, Flores, J, Cruceta, A, Varea, S, Miró, J M, Martínez, E, Gatell, J M

“…The use of HAART combining 2 nucleoside analogues reverse transcriptase inhibitors (NRTIs) plus one protease inhibitor (PI) or 2 NRTIs + 1 non-nucleoside…”
Get more information

Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients by PODZAMCZER, D, MIRO, J. M, POLO, R, LEYES, M, COSIN, J, FARINAS, M. C, ARRIZABALAGA, J, MARTINEZ-LACASA, J, GUDIOL, F, FERRER, E, GATELL, J. M, RAMON, J. M, RIBERA, E, SIRERA, G, CRUCETA, A, KNOBEL, H, DOMINGO, P

“…An open, randomised, multicentre trial was conducted to evaluate the efficacy of thrice-weekly versus daily therapy with sulfadiazine-pyrimethamine in the…”
Get full text

Substitution of Nevirapine, Efavirenz, or Abacavir for Protease Inhibitors in Patients with Human Immunodeficiency Virus Infection by Martínez, Esteban, Arnaiz, Juan A, Podzamczer, Daniel, Dalmau, David, Ribera, Esteban, Domingo, Pere, Knobel, Hernando, Riera, Melcior, Pedrol, Enric, Force, Lluis, Llibre, Josep M, Segura, Ferran, Richart, Cristóbal, Cortés, Cristina, Javaloyas, Manuel, Aranda, Miquel, Cruceta, Ana, de Lazzari, Elisa, Gatell, José M

“…In this randomized study of 460 patients receiving effective treatment for human immunodeficiency virus type 1 (HIV-1) disease, nevirapine, efavirenz, or…”
Get full text

Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial by Pericàs, J.M., Moreno, A., Almela, M., García-de-la-Mària, C., Marco, F., Muñoz, P., Peña, C., de Alarcón, A., del Río, A., Eworo, A., Cruceta, A., Paré, J.C., Mestres, C.A., Miró, J.M., Miró, José M., Moreno, Asunción, Pericàs, Juan M., Ambrosioni, Juan, Tellez, Adrián, Hernandez-Meneses, Marta, Río, Ana del, Cervera, Carlos, Marco, Francesc, Garcia de la Mària, Cristina, Armero, Yolanda, Almela, Manel, Mestres, Carlos A., Paré, Juan C., Fuster, David, Cartañá, Ramón, Ninot, Salvador, Azqueta, Manel, Sitges, Marta, Ramírez, Jose, Brunet, Merce, Soy, Dolors, Llopis, Jaume, Peña, Carmen, Gasch, Oriol, Suarez, Cristina, Pujol, Miquel, Ariza, Javier, Carratalà, Jordi, Gudiol, Francisco, Muñoz, Patricia, Eworo, Alia, Bouza, Emilio, de Alarcón, Arístides, Gurgui, Mercè, Benito, Natividad, Losa-Garcia, Juan-Emilio, Navas, Enrique, Paño-Pardo, Jose R., Loeches, Belén, Arribas, Jose R., Montejo, Miguel, Galvez, Juan

Get full text

Therapeutic Immunization with Dendritic Cells Loaded with Heat-Inactivated Autologous HIV-1 in Patients with Chronic HIV-1 Infection by García, Felipe, Lejeune, Merylene, Climent, Nuria, Gil, Cristina, Alcamí, José, Morente, Vanessa, Alós, Llucia, Ruiz, Alba, Setoain, Javier, Fumero, Emilio, Castro, Pedro, López, Anna, Cruceta, Anna, Piera, Carlos, Florence, Eric, Pereira, Arturo, Libois, Agnes, González, Nuria, Guilá, Meritxell, Caballero, Miguel, Lomeña, Francisco, Joseph, Joan, Miró, José M, Pumarola, Tomás, Plana, Montserrat, Gatell, José M, Gallart, Teresa

“…Therapeutic immunization with autologous monocyte-derived dendritic cells (DCs) loaded with heat-inactivated autologous human immunodeficiency virus type 1…”
Get full text

Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review by Diaz, Natalia A., Ambrosioni, Juan, Tuset, Montserrat, Brunet, Mercé, Cofan, Frederic, Crespo, Gonzalo, Ruiz, Pablo, Redondo-Pachón, Dolores, Crespo, Marta, Marín-Casino, Mónica, Moreno, Asunción, Miró, José M.

“…People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT represents…”
Get full text

Post-exposure prophylaxis for HIV infection: a clinical trial comparing lopinavir/ritonavir versus atazanavir each with zidovudine/lamivudine by Diaz-Brito, Vicens, León, Agathe, Knobel, Hernando, Peraire, Joaquim, Domingo, Pere, Clotet, Bonaventura, Dalmau, David, Cruceta, Anna, Arnaiz, Joan Albert, Gatell, Josep M, García, Felipe

“…A clinical trial comparing the rate of discontinuation and tolerability of two post-exposure prophylaxis (PEP) regimens was performed. A total of 255…”
Get more information

Boceprevir plus Peginterferon/Ribavirin to retreat HCV genotype-1 in HIV-HCV coinfected patients. Final results of BOC HIV-HCV Spanish Study by Laguno, M, Von Wichmann, M.A, Van den Eynde, E, Navarro, J, Cifuentes, C, Murillas, J, Veloso, S, Martínez-Rebollar, M, Guardiola, J.M, Jou, A, Sirvent, J.L. Gómez, Cervantes, M, Pineda, J.A, López-Calvo, S, Carrero, A, Montes, M.L, Deig, E, Tapiz, A, Ruiz-Mesa, J.D, Cruceta, A, de Lazzari, E, Mallolas, J

“…Highlights • Prospective, randomized clinical trial. • Safety and efficacy of RGT with BOC + pegylated interferon alpha 2a/ribavirin. • Retreatment of HCV-HIV…”
Get full text

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection by GARCIA, Felipe, PLANA, Montserrat, PUMAROLA, Tomas, GALLART, Teresa, NIXON, Douglas F, MIRO, José M, GATELL, José M, ORTIZ, Gabriel M, BONHOEFFER, Sebastian, SORIANO, Alex, VIDAL, Carmen, CRUCETA, Anna, ARNEDO, Mireia, GIL, Cristina, PANTALEO, Giuseppe

“…Some individuals with chronic HIV-1 infection have discontinued their drug therapy with consequent plasma virus rebound. In a small number of patients, a…”
Get full text

Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy by GARCIA, F, PLANA, M, VIDAL, C, CRUCETA, A, O'BRIEN, W. A, PANTALEO, G, PUMAROLA, T, GALLART, T, MIRO, J. M, GATELL, J. M

“…This study addresses the dynamic of viral load rebound and immune system changes in a cohort of eight consecutive HIV-1-infected patients in very early stages…”
Get full text

Effect of Penicillin Resistance of Streptococcus pneumoniae on the Presentation, Prognosis, and Treatment of Pneumococcal Endocarditis in Adults by Martínez, Esteban, Miró, Jose M., Almirante, Benito, Aguado, Jose M., Fernandez-Viladrich, Pedro, Guerrero, Manuel L. Fernandez, Villanueva, Jose L., Dronda, Fernando, Moreno-Torrico, Alfonso, Montejo, Miguel, Llinares, Pedro, Gatell, Jose M.

“…We performed a clinical study of pneumococcal endocarditis (PE) in adults at 15 major Spanish hospitals during a 21-year period (1978–1998). During this time,…”
Get full text

Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection by PLANA, Montserrat, GARCIA, Felipe, MIRO, José M, GATELL, José M, GALLART, Teresa, TORTAJADA, Cecilia, SORIANO, Alex, PALOU, Eduard, MALENO, Maria J, BARCELO, Juan J, VIDAL, Carmen, CRUCETA, Anna

“…To assess whether an almost complete restoration of immune system can be achieved when antiretroviral therapy is initiated at very early stages of asymptomatic…”
Get full text